157 related articles for article (PubMed ID: 23170932)
1. Major histocompatibility complex class-II molecules promote targeting of human immunodeficiency virus type 1 virions in late endosomes by enhancing internalization of nascent particles from the plasma membrane.
Finzi A; Perlman M; Bourgeois-Daigneault MC; Thibodeau J; Cohen ÉA
Cell Microbiol; 2013 May; 15(5):809-22. PubMed ID: 23170932
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.
Finzi A; Brunet A; Xiao Y; Thibodeau J; Cohen EA
J Virol; 2006 Oct; 80(19):9789-97. PubMed ID: 16973583
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.
Neil SJ; Eastman SW; Jouvenet N; Bieniasz PD
PLoS Pathog; 2006 May; 2(5):e39. PubMed ID: 16699598
[TBL] [Abstract][Full Text] [Related]
4. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
Ono A; Freed EO
J Virol; 2004 Feb; 78(3):1552-63. PubMed ID: 14722309
[TBL] [Abstract][Full Text] [Related]
5. Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.
Moldenhauer G; Henne C; Karhausen J; Möller P
Immunology; 1999 Mar; 96(3):473-84. PubMed ID: 10233730
[TBL] [Abstract][Full Text] [Related]
6. Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.
Porter KA; Kelley LN; George A; Harton JA; Duus KM
PLoS One; 2010 Jun; 5(6):e11304. PubMed ID: 20585587
[TBL] [Abstract][Full Text] [Related]
7. Plasma membrane is the site of productive HIV-1 particle assembly.
Jouvenet N; Neil SJ; Bess C; Johnson MC; Virgen CA; Simon SM; Bieniasz PD
PLoS Biol; 2006 Dec; 4(12):e435. PubMed ID: 17147474
[TBL] [Abstract][Full Text] [Related]
8. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes.
Schaeffer E; Soros VB; Greene WC
J Virol; 2004 Feb; 78(3):1375-83. PubMed ID: 14722292
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.
Van Damme N; Guatelli J
Cell Microbiol; 2008 May; 10(5):1040-57. PubMed ID: 18076669
[TBL] [Abstract][Full Text] [Related]
10. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization.
Roche PA; Teletski CL; Stang E; Bakke O; Long EO
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8581-5. PubMed ID: 8397411
[TBL] [Abstract][Full Text] [Related]
11. Imaging the biogenesis of individual HIV-1 virions in live cells.
Jouvenet N; Bieniasz PD; Simon SM
Nature; 2008 Jul; 454(7201):236-40. PubMed ID: 18500329
[TBL] [Abstract][Full Text] [Related]
12. Envelope glycoproteins are dispensable for insertion of host HLA-DR molecules within nascent human immunodeficiency virus type 1 particles.
Martin G; Beauséjour Y; Thibodeau J; Tremblay MJ
Virology; 2005 May; 335(2):286-90. PubMed ID: 15840527
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 matrix mutations that alter gag membrane binding modulate mature core formation and post-entry events.
Hikichi Y; Takeda E; Fujino M; Nakayama E; Matano T; Murakami T
Virology; 2019 Jun; 532():97-107. PubMed ID: 31055063
[TBL] [Abstract][Full Text] [Related]
14. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
[TBL] [Abstract][Full Text] [Related]
15. Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus-cell binding.
Murakami T; Carmona N; Ono A
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8055-8063. PubMed ID: 32193343
[TBL] [Abstract][Full Text] [Related]
16. A novel sorting strategy of trichosanthin for hijacking human immunodeficiency virus type 1.
Zhao WL; Zhang F; Feng D; Wu J; Chen S; Sui SF
Biochem Biophys Res Commun; 2009 Jul; 384(3):347-51. PubMed ID: 19409877
[TBL] [Abstract][Full Text] [Related]
17. Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.
Joshi A; Ablan SD; Soheilian F; Nagashima K; Freed EO
J Virol; 2009 Jun; 83(11):5375-87. PubMed ID: 19297499
[TBL] [Abstract][Full Text] [Related]
18. Inhibition or deficiency of cathepsin B leads defects in HIV-1 Gag pseudoparticle release in macrophages and HEK293T cells.
Ha SD; Park S; Hattlmann CJ; Barr SD; Kim SO
Antiviral Res; 2012 Jan; 93(1):175-84. PubMed ID: 22138708
[TBL] [Abstract][Full Text] [Related]
19. Defective HIV-1 particle assembly in AP-3-deficient cells derived from patients with Hermansky-Pudlak syndrome type 2.
Liu L; Sutton J; Woodruff E; Villalta F; Spearman P; Dong X
J Virol; 2012 Oct; 86(20):11242-53. PubMed ID: 22875976
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cell surface molecules during HIV-1 infection of H9 cells. An immunoelectron microscopic study.
Meerloo T; Parmentier HK; Osterhaus AD; Goudsmit J; Schuurman HJ
AIDS; 1992 Oct; 6(10):1105-16. PubMed ID: 1466841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
